Skip to main content
. 2022 Jun 1;27(8):e625–e632. doi: 10.1093/oncolo/oyac097
Number of patients, male 11
Number of patients, female 13
Stage IV
Age: median (range) 57 (22.3-69.8) years
Number of prior systemic therapies: median (range) 2 (1-6)
Performance status: ECOG 0-7
1-17
2-0
3-0
4-0
Cancer types or histologic subtypes Neuroendocrine carcinoma, 18; Neuroendocrine tumor , 16
Note The primary tumor site of 10 patients was gastrointestinal and that of 7 was pancreatic. The other primary sites included liver (n = 2), lung (n=1), adrenal gland (n = 1), cervix (n = 1), and sacroiliac (n = 1). The median Ki-67 was 60%.